Indian Journal of Dermatology
THERAPEUTIC ROUND
Year
: 2010  |  Volume : 55  |  Issue : 4  |  Page : 355--358

Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir


Farah Sameem1, Iffat Hassan1, Qazi Masood Ahmad1, Dilshad Khan1, Imran Majeed1, MA Kamili2, Parvaiz A Shah2 
1 Department of Dermatology, STD and Leprosy, Government Medical College, Srinagar, Jammu and Kashmir, India
2 Department of Internal Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India

Correspondence Address:
Iffat Hassan
Department of Dermatology, STD and Leprosy, Government Medical College, Karan Nagar, Srinagar - 190 010, Jammu and Kashmir
India

Background: Systemic sclerosis is a multisystemic autoimmune disorder. Intravenous dexamethasone pulse therapy has been used since 1998. Aim: The aim was to report the beneficial effects of dexamethasone pulse in patients of systemic sclerosis vis-á-vis the side effects. Materials and Methods: Forty-seven patients of systemic sclerosis were included. After looking at the history and physical examination, the patients were submitted to various relevant investigations. Clinical scoring of the patient was done at baseline and 6-month interval according to Furst«SQ»s organ indices score. Results: A total of 47 patients of systemic sclerosis were included (45 females, 2 males). In majority, acrosclerosis was seen. Severe sclerosis and contractures were seen in two patients. Moderate proteinuria, restrictive lung disease, dysphagia, and valvular heart involvement were seen. A total of 13 patients on dexamethasone pulse therapy developed tuberculosis. Improvement in skin scoring and decreased severity of Raynaud«SQ»s phenomenon was seen. No improvement in dysphagia, severe vascular symptoms, or restrictive lung disease was seen. Conclusion: Thus, beneficial effects of dexamethasone pulse therapy seem to be merely cosmetic.


How to cite this article:
Sameem F, Hassan I, Ahmad QM, Khan D, Majeed I, Kamili M A, Shah PA. Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir.Indian J Dermatol 2010;55:355-358


How to cite this URL:
Sameem F, Hassan I, Ahmad QM, Khan D, Majeed I, Kamili M A, Shah PA. Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir. Indian J Dermatol [serial online] 2010 [cited 2019 Sep 18 ];55:355-358
Available from: http://www.e-ijd.org/article.asp?issn=0019-5154;year=2010;volume=55;issue=4;spage=355;epage=358;aulast=Sameem;type=0